COVID-19 GPH|Home|PHGKB

COVID-19 GPH|Home|PHGKB

 Spotlight

Coronavirus reinfections: three questions scientists are asking
H Ledford, Nature News, September 7, 2020

Second infections raise three questions about long-term immunity to COVID-19 and the prospects for a vaccine: how common are reinfections, how severe are they, and what are the implications for vaccine development?

Microbe tests in the NIH Genetic Testing Registry
NIH Genetic Testing Registry, September 2020

GTR now has tests for microbes like for SARS-CoV-2 to diagnose COVID-19. Scope includes pathogen-specific genetic tests; panels to identify pathogens; tests that assess viral load; serologic tests for detection of antibodies and antigens to determine prior exposure.

NIH Genetic Testing Registry (GTR) now accepting microbe tests including SARS-CoV-2 / COVID-19 tests
NCBI, September 2020

The profound impact of the COVID-19 pandemic prompted the NIH Genetic Testing Registry (GTR) to expand its scope to include microbe tests. We will focus initially on molecular tests to detect the SARS-CoV-2 virus and serology tests to detect viral antigens and antibodies to the virus.

The association between ABO blood group and SARS-CoV-2 infection: a meta-analysis
D Golinelli et al, MEDRXIV, September 3, 2020

The results of our meta-analysis indicate that SARS-CoV-2 positive individuals are more likely to have blood group A (pooled OR 1.23, 95%CI: 1.09-1.40) and less likely to have blood group O (pooled OR=0.77, 95%CI: 0.67-0.88).